UNIVERSITY OWNED PATENTS
Patents can be viewed by clicking on a Patent number, a PDF of the the patent will open in a new window. To view an Non-confidential Summary of the Technology, click on a file number.
File # |
Country |
Patent No. |
Patent Title |
United States |
Regulation Of NAD (P) H Oxidase Growth And Transcription Melanoma Cells |
||
United States |
Method Of Treating Cancer Using Tetraethyl Thiuram Disulfide |
||
Australia |
782029 |
Method of Treating Cancer Using Tetraethyl Thiuram Disulfide |
|
Europe |
Method of Treating Cancer Using Tetraethyl Thiuram Disulfide |
||
United States |
Method Of Treating Cancer Using Dithiocarbamate Derivatives |
||
United States |
Method Of Treating Cancer Using Dithiocarbamate Derivatives |
||
Europe |
Pharmaceutical Compositions Containing Alkylaryl Polyether Alcohol Polymer |
||
United States |
Pharmaceutical Compositions Containing Alkylaryl Polyether Alcohol Polymer |
||
Canada |
2,216,789 |
Method Of Mucociliary Clearance In Cystic Fibrosis Patients Using Alkylaryl Polyether Alcohol Polymers |
|
Austria |
Compositions Containing Alkylaryl |
||
Great Britain |
Compositions Containing Alkylaryl |
||
Australia |
717537 |
Method Of Mucociliary Clearance In Cystic Fibrosis Patients Using Alkylaryl Polyether Alcohol Polymers |
|
France |
Compositions Containing Alkylaryl |
||
United States |
Pharmaceutical Compositions Containing Alkylaryl Polyether Alcohol Polymer |
||
United States |
Treatment Of Chronic Pulmonary Inflammation |
||
New Zealand |
263986 |
Method Of Inhibiting Oxidants Using Alkylaryl Polyether Alcohol Polymers |
|
Canada |
2,159,485 |
Method Of Inhibiting Oxidants Using Alkylaryl Polyether Alcohol Polymers |
|
United States |
Method Of Inhibiting Oxidants Using Alkylaryl Polyether Alcohol Polymers |
||
Ireland |
Compostitions Containing Alkylaryl |
||
Italy |
Compositions Containing Alkylaryl |
||
United States |
Method Of Inhibition Oxidants Using Alkylaryl Polyether Alcohol Polymers |
||
United States |
Method Of Mucociliary Clearance In Cystic Fibrosis Patients Using Alkylaryl Polyether AlcoholPloymers |
||
United States |
Method of Solution-based Scanning for Alterations in a DNA Segment Using a Double-stranded DNA Binding Dye and Fluorescence Melting Profiles |
||
United States |
Method for Prediction Prostate Cancer Patients' Resistance to Hormonal Treatment by Measuring Serum Concentrations of Chromogranin A |
||
United States |
Method of Analyzing Dicarboxylic Acids |
||
U-3642 |
United States |
TXu1-117-224 |
Providers United For Improving Inhaler Technique (PUFIIT SCALE) |
United States |
TXU- 1-050-648 |
Corrosion Virtual Lab |
|
United States |
Disposable Electromagnetic Fluid Level Sensor |
||
United States |
Noninvasive Electromagnetic Fluid Level Sensor |
||
United States |
Continuous Wave Ultrasonic Process Monitor for Polymer Processing |
||
United States |
MED PED FH Make Early Diagnoses - Prevent Early Deaths and Design |
||
United States |
TXU 1-050-649 |
Corrosion Course Modules |
|
United States |
Remediation with Ozone of Sediments Containing Organic Contaminants |
||
United States |
A Current Steering Folding Circuit |
||
United States |
Soluble Steroidal Peptides for Nuclear Acid Delivery |
||
United States |
Method of Use of Erythropoietin to Treat Ischemic Acute Renal Failure |
||
New Zealand |
523276 |
Compositions and Methods for Increasing the Oral Absorption of Antimicrobials |
|
South Africa |
2002/10289 |
Compositions and Methods for Increasing the Oral Absorption of Antimicrobials |
|
United States |
Complexes to Improve Oral Absorption of Poorly Absorbable Antibiotics |
||
U-3191 |
United States |
Mu-Conopeptides |
|
U-3189 |
United States |
I-Superfamily Conotoxins |
|
United States |
Medical Broad Band Electromagnetic Holographic Imaging |
||
United States |
High Frequency Thermoacoustic Refrigerator |
||
U-3184 |
United States |
Method of Isolating Human Neuroepithelial Precursor Cells from Human Fetal Tissue |
|
U-3174 |
United States |
Use of Conantokins for Producing Analgesia or for Neuroprotection |
|
U-3174 |
United States |
Use of Conantokins for Producing Analgesia or for Neuroprotection |
|
United States |
Measurement of Crude Oil Wax Precipitation Temperatures and Precipitated Solid Weight Percent Versus Temperature by Infrared Spectroscopy |
||
United States |
Structured Organic Materials and Devices Using Low-Energy Paritcle Beams |
||
United States |
Submerged Ammonia Removal System and Method |
||
U-3032 |
United States |
Single-Labeled Oligonucleotide Probes for Homogeneous Nucleic Acid Sequence Analysis |
|
U-3021 |
Europe |
Color Compensation for Temperature and Electronic Gains |
|
U-3021 |
Japan |
3657556 |
Color Compensation for Temperature and Electronic Gains |
U-3019 |
United States |
Multi-Test Analysis of Real-Time Nucleic Acid Amplification |
|
U-3018 |
United States |
Method for Quantification of an Analyte |
|
U-3018 |
United States |
Method for Quantification of an Analyte |
|
U-3007 |
United States |
O-Superfamily Conotoxin Peptides |
|
U-2970 |
United States |
Method and Apparatus for Raman Imaging of Macular Pigments |
|
United States |
Mass1 Gene, A Target for Anticonvulsant Drug Development |
||
U-2958 |
United States |
Contryphan Peptides |
|
U-2958 |
United States |
Contryphan Peptides |
|
Australia |
780350 |
Elastin-Based Compositions |
|
United States |
Methods for Extracting Substances Using Alternating Current |
||
U-2907 |
Australia |
768091 |
Tau-Conotoxin Peptides |
U-2907 |
United States |
Tau-Conotoxin Peptides |
|
U-2904 |
Australia |
735724 |
Use of Conotoxin Peptides ImI and MII as Cardiovascular Agents |
U-2903 |
United States |
Use of Conantokins for Treating Pain |
|
U-2903 |
Australia |
735389 |
Use of Conantokins |
U-2903 |
United States |
Use of Conantokins |
|
U-2903 |
United States |
Use of Conantokins |
|
U-2902 |
United States |
Alpha-Conotoxin Peptides |
|
U-2902 |
United States |
Conotoxin Peptides |
|
U-2901 |
Australia |
778353 |
Alpha-Conotoxin Peptides |
U-2901 |
United States |
Alpha-Conotoxin Peptides |
|
U-2901 |
United States |
Alpha-Conotoxin Peptides |
|
U-2897 |
United States |
Contulakin-G, Analogs Thereof and Uses Therefor |
|
U-2897 |
United States |
Contulakin-G, Analogs Thereof and Uses Therefor |
|
U-2897 |
United States |
Contulakin-G, Analogs Thereof and Uses Therefor |
|
U-2896 |
United States |
Methods for Purifying and Assaying a Conus Gamma-Glutamyl Carboxylase |
|
U-2895 |
United States |
Uses of Alpha-Conotoxin Peptides |
|
U-2893 |
United States |
Use of Alpha-Conotoxin MII to Treat Disorders Resulting from Nicotine-Stimulated Dopamine Release |
|
U-2893 |
United States |
Use of Alpha-Conotoxin MII to Treat Disorders Resulting from Nicotine-Stimulated Dopamine Release |
|
U-2893 |
United States |
Use of Alpha-Conotoxin MII to Treat Disorders Resulting from Nicotine-Stimulated Dopamine Release |
|
U-2892 |
United States |
Gamma-Conopeptides |
|
U-2891 |
United States |
Bromo-Tryptophan Conopeptides |
|
U-2890 |
United States |
Contryphan Peptides |
|
U-2889 |
United States |
Conotoxin Peptides AuIA, AuIB and AuIC |
|
U-2888 |
Australia |
727196 |
Conantokins |
U-2888 |
United States |
Conantokins |
|
U-2887 |
Europe |
Conotoxin Peptide PVIIA |
|
U-2887 |
Australia |
724408 |
Conotoxin Peptide PVIIA |
U-2887 |
United States |
Conotoxin Peptide PVIIA |
|
U-2886 |
United States |
Conotoxin Peptide PIIIA |
|
U-2885 |
Australia |
700592 |
Conotoxin Peptides |
U-2885 |
United States |
Conotoxin Peptides |
|
U-2885 |
United States |
Conotoxin Peptides |
|
U-2885 |
United States |
Conotoxin Peptides |
|
U-2884 |
United States |
Omega-Conotoxin Peptides |
|
United States |
Simultaneous Screening and Identification of Sequence Alterations from Amplified Target |
||
United States |
Method to Determine Predisposition to Hypertension |
||
United States |
Fluorescent Cobalamins and Uses Thereof |
||
United States |
Fluorescent Cobalamins and Uses Thereof |
||
United States |
Alterations in the Long QT Syndrome Genes KVLQT1 and SCN5A and Methods for Detecting Same |
||
Australia |
779477 |
Alterations in the Long QT Syndrome Genes KVLQT1 and SCN5A and Methods for Detecting Same |
|
United States |
Alterations in the Long QT Syndrome Genes KVLQT1 and SCN5A and Methods for Detecting Same |
||
United States |
Coaxial Continuous Transverse Stub Element Device Antenna Array and Filter |
||
United States |
Selective Flotation of Phosphate Minerals with Hydroxamate Collectors |
||
United States |
Transgenic Mouse with Endogenous Endoglin Gene Disruption |
||
United States |
Low Temperature Chemical Vapor Depostion of Thin Film Magnets |
||
Australia |
778566 |
MinK-Related Genes, Formation of Potassium Channels and Association with Cardiac Arrhythmia |
|
United States |
MinK-Related Genes, Formation of Potassium Channels and Association with Cardiac Arrhythmia |
||
United States |
Method and Apparatus for Enhancing an Image Using Data Optimization and Segmentation |
||
United States |
Homogeneous Multiplex PCR by Color and Tm |
||
Australia |
780376 |
Cystal Structure of Ribosomal Protein L11/GTPase |
|
United States |
Crystal Structure of Ribosomal Protein L11/GTPase |
||
United States |
Nematode Neuromuscular Junction GABA Receptors and Methods Related Thereto |
||
United States |
Nematode Neuromuscular Junction GABA Receptors and Methods Related Thereto |
||
United States |
Molecular Decomposition Process for the Synthesis of Nanosize Ceramic Powders |
||
Australia |
758256 |
A Molecular Decomposition Process for the Synthesis of Nanosize Ceramic Powders |
|
U-2723 |
United States |
Multiplex Genotyping Using Fluorescent Hybridization Probes |
|
U-2723 |
Japan |
3670967 |
Multiplex Genotyping Using Fluorescent Hybridization Probes |
United States |
Method of Digital Image Enhancement and Sharpening |
||
United States |
Raman Spectroscopy Apparatus and Method for Continuous Cehmical Analysis of Fluid Streams |
||
United States |
Des. 426,783 |
Waveguide Lens |
|
United Kingdom |
2081554 |
Waveguide Lens |
|
Denmark |
MR 1999 00991 |
Waveguide Lens |
|
Switzerland |
125,888 |
Waveguide Lens |
|
Great Britain |
2081553 |
Waveguide Lens |
|
France |
546542 to 546562 |
Waveguide Lens |
|
U-2705 |
United States |
Electrosurgical Electrode with a Conductive, Non-Stick Coating |
|
U-2704 |
United States |
Method and Apparatus for Providing a Conductive, Amorphous Non-Stick Coating |
|
U-2703 |
United States |
Mucin Containing Ophthalmic Preparation |
|
U-2703 |
United States |
Mucin Containing Ophthalmic Preparations |
|
United States |
Drug Screening and Diagnosis Based on Paracrine Tubular Renin-Angiotensin System |
||
U-2669 |
Australia |
771635 |
Methods for Treating Conditions Associated with the Accumulation of Excess Extracellular Matrix |
Australia |
774194 |
MUTATIONS IN AND GENOMIC STRUCTURE OF HERG-A LONG QT SYNDROME GENE |
|
United States |
Mutations In and Genomic Structure of HERG - a Long QT Syndrome Gene |
||
United States |
Actin Mutations in Dilated Cardiomyopathy, a Heritable Form of Heart Failure |
||
United States |
Stabilization and Acoustic Activation of Polymeric Micelles for Drug Delivery |
||
U-2612 |
United States |
Methods and Apparatus for Noninvasive Measurement of Carotenoids and Related Chemical Substances in Biological Tissue |
|
United States |
Circular, Hairpin, Circular/Hairpin, lariat, and Hairpin-Lariat Hammerhead Ribozymes |
||
United States |
Human Diacylglycerol Kinase Iota |
||
U-2565 |
United States |
Micromachined Electrical Field-Flow Fractionation System |
|
United States |
Vesicular Amino Acid Transported Composition and Method |
||
United States |
SID-Polyamide Fusions: A Potent Method of Regulating Gene Expression |
||
United States |
Electrical Detector for Micro-Analysis Systems |
||
United States |
Diagnostic Device and Method |
||
Canada |
2,303,794 |
Diagnostic Device and Method |
|
U-2538 |
United States |
Process for Conversion of Lignin to Reformulated, Partially Oxygenated Gasoline |
|
U-2538 |
United States |
Process for Conversion of Lignin to Reformulated Hydrocarbon Gasoline |
|
U-2536 |
United States |
Lineage Restricted Glial Precursors from the Central Nervous System |
|
U-2536 |
Australia |
765517 |
Lineage-Restricted Precursor Cells Isolated from Mouse Neural Tube and Mouse Embryonic Stem Cells |
U-2536 |
United States |
Lineage Restricted Glial Precursors from the Central Nervous System |
|
United States |
Dual Drive Planetary Mill |
||
United States |
Method for Improving Spatial Resolution and Accuracy in Scanning Probe Microscopy |
||
United States |
KCNQ2 and KCNQ3 - Potassium Channel Genes Which Are Mutated in Benign Familial Neonatal Convulsions (BFNC) and Other Epilepsies |
||
United States |
Mice Which Are +/- or -/- for the Elastin Gene as Models for Vascular Disease |
||
United States |
Human Antithrombin IIIs and Methods Related Thereto |
||
United States |
Organ Preservative Solution Containing Trehalose, Anti-Oxidant, Cations and an Energy Source |
||
South Africa |
98/5887 |
Lineage Restricted Neuronal Precursors |
|
United States |
Isolation of Lineage-Restricted Neuronal Precursors |
||
Australia |
755657 |
Lineage-Restricted Neuronal Precursors |
|
United States |
Method for Preparation of Polythylene Glycol Adehyde Deriviatives |
||
United States |
A Homozygous Mutation in KVLQT1 Which Causes Jervell and Lange-Neilsen Syndrome |
||
United States |
Mutations in the KCNE1 Gene Encoding Human minK Which Cause Arrhythmia Susceptibility Thereby Establishing KCNE1 as an LQT Gene |
||
United States |
Mutations in the KCNE1 Gene Encoding Human minK Which Cause Arrhythmia Susceptibility Thereby Establishing KCNE1 as an LQT Gene |
||
United States |
KVLQT1-A Long QT Syndrome Gene |
||
Australia |
758048 |
KVLQT1 - A LONG QT SYNDROME GENE |
|
United States |
Mutations in the KCNE1 Gene Encoding Human minK whichCause Arrhythmia Susceptibility Therby Establishing KCNE1 as an LQT Gene |
||
U-2455 |
United States |
Metal-Chelating Surfacant |
|
U-2433 |
United States |
Raman Spectroscopy Apparatus and Method Using External Cavity Laser for Continuous Chemical Analysis of Sample Streams |
|
U-2425 |
United States |
Methods for Preventing and Treating Fibrotic Diseases Resulting from Accumulation of Excess Extracellular Matrix Induced by TGFBeta Using Renin Inhibitors |
|
United States |
Dual-Luciferase Reporter System |
||
United States |
Magnetostrictive Composites and Process for Manufacture by Dynamic Compaction |
||
U-2402 |
United States |
Chromosome 17p-Linked Prostate Cancer Susceptibility Gene |
|
U-2402 |
United States |
Chromosome 17P-Linked Prostate Cancer Susceptibility Gene and A Paralog and Orthologous Genes |
|
U-2396 |
United States |
High Power Density Solid Oxide Fuel Cell Having a Graded Anode and the Fuel Cell Thereof |
|
U-2383 |
Australia |
751581 |
Generation, Characterization and Isolation of Neuroepithelial Stem Cells and Lineage Restricted Intermediate Precursor |
U-2383 |
Israel |
132584 |
Generation, Characterization, and Isolation of Neuroepithelial Stem Cells and Lineage Restricted intermediate Precursor |
U-2383 |
United States |
Neuroepithelial Stem Cells and Glial-Restricted Intermediate Precursors |
|
U-2383 |
United States |
Common Neural Progenitor for the CNS and PNS |
|
U-2376 |
Australia |
722998 |
Electromagnetically Suspended and Rotated Centrifugal Pumping Apparatus and Method |
U-2376 |
Australia |
741418 |
Implantable Centrifugal Blood Pump with Hybrid Magnetic Bearings |
U-2376 |
Australia |
735578 |
Hybrid Magnetically Suspended and Rotated Centrifugal Pumping Apparatus and Method |
U-2376 |
Australia |
766439 |
Hybrid Magnetically Suspended and Rotated Centrifugal Pumping Apparatus and Method |
U-2376 |
United States |
Electromagnetically Suspended and rotated Centrifugal Pumping Apparatus and Method |
|
U-2376 |
Canada |
2,253,435 |
Hybrid Magnetically Suspended and Rotated Centrifugal Pumping Apparatus and Mehtod |
U-2376 |
United States |
Hybrid Magnetically Suspended and Rotated Centrifugal Pumping Apparatus and Method |
|
U-2376 |
United Kingdom |
0897476 |
Hybrid Magnetically Suspended and Rotated Centrigugal Pumping Apparatus and Method |
Europe |
Prodrugs and Conjugates of Thiol-and Selenol-Containing Compounds and Methods of Use Thereof |
||
United States |
Prodrugs and Conjugates of Thiol-and Selenol-Containing Compounds and Methods of Use Thereof |
||
Australia |
750916 |
Prodrugs and Conjugates of Thiol-and Selenol-Containing Compounds and Methods of Use Thereof |
|
United States |
DEVICE AND METHOD FOR PRECISION MACULAR IRRADIATOR |
||
United States |
Device and Method for Precision Macular Irradiator |
||
Canada |
2,317,896 |
Method for In Vitro Amplification of Circular DNA |
|
United States |
Method for In Vitro Amplification of Circular DNA |
||
United States |
Improved Rapid Prototyping Method |
||
U-2336 |
United States |
Methods for Preparing Devices Having Metallic Hollow Microchannels on Planar Substrate Surfaces |
|
U-2336 |
United States |
Methods for Preparing Devices Having Metallic Hollow Microchannels on Planar Substrate Surfaces |
|
U-2334 |
United States |
Method and System for Measurement of Macular Carotenoid Levels |
|
U-2334 |
Europe |
Method and System for Measurement of Macular Carotenoid Levels |
|
United States |
Bioconjugates and Delivery of Bioactive Agents |
||
United States |
Bioconjugates and Delivery of Bioactive Agents |
||
United States |
Bioconjugates and Delivery of Bioactive Agents |
||
United States |
Bioconjugates and Delivery of Bioactive Agents |
||
Australia |
738431 |
Bioconjugates and Delivery of Bioactive Agents |
|
New Zealand |
334870 |
Bioconjugates and Delivery of Bioactive Agents |
|
United States |
Method of Broad Band Electromagnetic Holographic Imaging |
||
U-2313 |
United States |
Image Reconstruction for Compton Camera Including Spherical Harmonics |
|
U-2313 |
United States |
Image Reconstruction from V-projections Acquired by Compton Camera |
|
U-2301 |
Australia |
729644 |
System and Method for Carrying Out and Monitoring Biological Processes |
U-2301 |
Europe |
Monitoring Hybridization During PCR Using SybrGreen |
|
U-2301 |
Sweden |
Monitoring Hybridization During PCR |
|
U-2301 |
United States |
Monitoring Amplification of DNA During PCR |
|
U-2301 |
Greece |
Monitoring Hybridization During PCR |
|
U-2301 |
United States |
PCR Method for Nucleic Acid Quantification |
|
U-2301 |
Europe |
System and Method for Carrying Out and Monitoring Polymerase Chain Reactions |
|
U-2301 |
Portugal |
Monitoring Hybridization During PCR |
|
U-2301 |
Australia |
726501 |
Monitoring Hybridization During PCR |
U-2301 |
Republic of Korea (South Korea) |
0479789 |
Monitoring Hybridization During PCR |
U-2301 |
Spain |
System and Method for Carrying Out and Monitoring Polymerase Chain Reactions |
|
U-2301 |
Italy |
System and Method for Carrying Out and Monitoring Polymerase Chain Reactions |
|
U-2301 |
New Zealand |
502323 |
Monitoring Hybridization During PCR |
U-2301 |
Republic of Korea (South Korea) |
0479782 |
System and Method for Carrying Out and Monitoring Biological Processes |
U-2301 |
Belgium |
System and Method for Carrying Out and Monitoring Polymerase Chain Reactions |
|
U-2301 |
Great Britain |
Monitoring Hybridization During PCR |
|
U-2301 |
Ireland |
System and Method for Carrying Out and Monitoring Polymerase Chain Reactions |
|
U-2301 |
Sweden |
System and Method for Carrying Out and Monitoring Polymerase Chain Reactions |
|
U-2301 |
Switzerland |
System and Method for Carrying Out and Monitoring Polymerase Chain Reactions |
|
U-2301 |
France |
System and Method for Carrying Out and Monitoring Polymerase Chain Reactions |
|
U-2301 |
Great Britain |
System and Method for Carrying Out and Monitoring Polymerase Chain Reactions |
|
U-2301 |
Netherlands |
System and Method for Carrying Out and Monitoring Polymerase Chain Reactions |
|
U-2301 |
Netherlands |
Monitoring Hybridization During PCR |
|
U-2301 |
Republic of Korea (South Korea) |
0479767 |
System and Method for Monitoring for DNA Amplification by Fluorescence |
U-2301 |
Australia |
727296 |
System and Method for Monitoring for DNA Amplification by Fluorescence |
U-2301 |
Monaco |
Monitoring Hybridization During PCR |
|
U-2301 |
Belgium |
Monitoring Hybridization During PCR |
|
U-2301 |
Switzerland |
Monitoring Hybridization During PCR |
|
U-2301 |
Denmark |
Monitoring Hybridization During PCR |
|
U-2301 |
Spain |
Monitoring Hybridization During PCR |
|
U-2301 |
Luxembourg |
Monitoring Hybridization During PCR |
|
U-2301 |
Germany |
697 27 932.4-08 |
System and Method for Carrying Out and Monitoring Polymerase Chain Reactions |
U-2301 |
Italy |
Monitoring Hybridization During PCR |
|
U-2301 |
Ireland |
Monitoring Hybridization During PCR |
|
U-2301 |
Finland |
Monitoring Hybridization During PCR |
|
U-2301 |
France |
Monitoring Hybridization During PCR |
|
U-2295 |
United States |
Method and Apparatus for Analysis of Chromatographic Migration Patterns |
|
United States |
System for Determining Analyte Concentration |
||
Australia |
768,800 |
System for Determining Analyte Concentration |
|
United States |
Oscillation Apparatus and Methods for Multi-Analyte Homogeneous Fluoro-Immunoassays |
||
United States |
Lens and Associatable Flow Cell |
||
United States |
Lens and Associatable Flow Cell |
||
United States |
Lens and Associatable Flow Cell |
||
United States |
Variable Analog Delay Line for Analog Signal Processing on a Single Integrated Circuit Chip |
||
United States |
Diacylglycerol Kinase Isoforms Epsilon and Zeta and Methods of Use Thereof |
||
United States |
Diacylglycerol Kinase Isoforms Epsilon and Zeta and Methods of Use Thereof |
||
United States |
Spinal Fixation Device with Laterally Attachable Connectors |
||
New Zealand |
330743 |
A LONG QT SYNDROME GENE WHICH ENCODES KVQT1 AND ITS ASSOCIATION WITH minK |
|
Japan |
3449419 |
A LONG QT SYNDROME GENE WHICH ENCODES KVQT1 AND ITS ASSOCIATION WITH minK |
|
Australia |
714527 |
KVLQT1-A Long QT Syndrome Gene Which Encodes KVLQT1 Which Coassembles with minK to form Cardiac Iks Potassium Channels |
|
Republic of Korea (South Korea) |
508845 |
A LONG QT SYNDROME GENE WHICH ENCODES KVQT1 AND ITS ASSOCIATION WITH minK |
|
Australia |
714041 |
A LONG QT SYNDROME GENE WHICH ENCODES KVQT1 AND ITS ASSOCIATION WITH minK |
|
United States |
KVLQT1 A Long QT Syndrome Gene |
||
United States |
KVLQT1 - A Long QT Syndrome Gene |
||
United States |
KVLQT1 - A Long QT Syndrome Gene |
||
United States |
KVLQT1 - A Long QT Syndrome Gene |
||
New Zealand |
330744 |
A LONG QT SYNDROME GENE WHICH ENCODES KVQT1 AND ITS ASSOCIATION WITH minK |
|
United States |
KVLQT1 - A Long QT Syndrome Gene |
||
United States |
Compositions for the Diagnosis and Treatment of Chediak-Higashi Syndrome |
||
United States |
Compositions for the Diagnosis and Treatment of Chediak-Higashi Syndrome |
||
Australia |
717109 |
Cationic Polymer and Lipoprotein-Containing System for Gene Therapy |
|
Republic of Korea (South Korea) |
0536979 |
Cationic Polymer and Lipoprotein-Containing System for Gene Delivery |
|
United States |
Cationic Polymer and Lipoprotein-Containing System for Gene Delivery |
||
United States |
Micromachined Probes for Nanometer Scale Measurements and Methods of Making Such Probes |
||
United States |
Stabilization and Oral Delivery of Calcitonin |
||
United States |
Active Microtubule-Based Separations by Kinesins |
||
United States |
Synthesis of Insulin Derivatives |
||
U-2187 |
United States |
Spiral Cervical Retractor Apparatus |
|
U-2178 |
United States |
Chromosome 11-Linked Coronary Heart Disease Susceptibility Gene CHD1 |
|
United States |
Culture Method for Multilayer Growth of Anchorage-Dependent Cells |
||
U-2167 |
United States |
Method for Mapping Mechanical Property of a Material Using a Scanning Force Microscope |
|
United States |
Scanning Tunneling Charge Transfer Microscope |
||
U-2147 |
United States |
Apparatus and Method for Enhanced Dermal Permeation of Pharmaceuticals |
|
United States |
Device for Radiation Therapy of Rectal Cancer |
||
U-2134 |
United States |
Three-Dimensional SPECT Reconstruction of Combined Cone Beam and Fan Beam Data |
|
United States |
Highlighting Quoted Passages in a Hypertext System |
||
United States |
Targeting of PEG Antibody Conjugates to Islet Cells |
||
United States |
Endotracheal Tube Splitter |
||
United States |
Endotracheal Tube Splitter |
||
U-2090 |
Europe |
17q-Linked Breast and Ovarian Cancer Susceptibility Gene |
|
U-2090 |
Europe |
17q-Linked Breast and Ovarian Cancer Susceptibility Gene |
|
U-2090 |
Greece |
3035631 |
17q-Linked Breast and Ovarian Cancer Susceptibility Gene |
U-2090 |
United States |
17q-Linked Breast and Ovarian Cancer Susceptibility Gene |
|
U-2090 |
Sweden |
17q-Linked Breast and Ovarian Cancer Susceptibility Gene |
|
U-2090 |
New Zealand |
291624 |
Method for Diagnosing a Predisposition for Breast and Ovarian Cancer |
U-2090 |
New Zealand |
291330 |
17q-Linked Breast and Ovarian Cancer Susceptibility Gene |
U-2090 |
Japan |
3399539 |
A Method for Diagnosing a Predisposition for Breast and Ovarian Cancer |
U-2090 |
Canada |
2,196,797 |
In Vivo Mutations and Polymorphisms in the 17q-Linked Breast and Ovarian Cancer Susceptibility Gene |
U-2090 |
Canada |
2,196,795 |
Method for Diagnosing a Predisposition for Breast and Ovarian Cancer |
U-2090 |
Canada |
2,196,790 |
17q-Linked Breast and Ovarian Cancer Susceptibility Gene |
U-2090 |
Australia |
2196795 |
Method for Diagnosing A Predisposition for Breast and Ovarian Cancer |
U-2090 |
United States |
A 14 Kilobase Deletion in the Promoter Region of BRCA1 in a Breast Cancer Family |
|
U-2090 |
United States |
17q-Linked Breast and Ovarian Cancer Susceptibility Gene |
|
U-2090 |
United States |
17q-Linked Breast and Ovarian Cancer Susceptibility Gene |
|
U-2090 |
Germany |
DE 695 24 182 T 2 |
17q-Linked Breast and Ovarian Cancer Susceptibility Gene |
U-2090 |
Greece |
3038516 |
|
U-2090 |
Denmark |
DK/EP 0705902 T3 |
17q-Linked Breast and Ovarian Cancer Susceptibility Gene |
U-2090 |
United States |
17q-Linked Breast and Ovarian Cancer Susceptibility Gene |
|
U-2090 |
Greece |
3036322 |
17q-Linked Breast and Ovarian Cancer Susceptibility Gene |
U-2090 |
Australia |
773601 |
Chromosome 13-Linked Breast Cancer Susceptibility Gene |
United States |
Continuous Solvent Extraction with Bottom Gas Injection |
||
United States |
Formation and Applications of AlCuFe Quasicrystalline Thin Films |
||
United States |
Higher Order Construction Algorithm Method for Rapid Prototyping |
||
United States |
Improved Rapid Prototyping Method |
||
United States |
Quantitative Two-Dimensional Dopant Profile Measurement and Inverse Modeling by Scanning Capacitance Microscopy |
||
U-2059 |
United States |
Methods for Detecting Predisposition to Cancer at the MTS Gene |
|
U-2058 |
New Zealand |
284612 |
Germline Mutations in the MTS Gene and Method for Detecting Predisposition to Cancer at the MTS Gene |
U-2058 |
Australia |
685627 |
Germline Mutations in the MTS Gene and Method for Detecting Predisposition to Cancer at the MTS Gene |
U-2058 |
New Zealand |
328515 |
Germline Mutations in the MTS Gene and Method for Detecting Predisposition to Cancer at the MTS Gene |
U-2058 |
United States |
Germline Mutations in the MTS Gene |
|
U |

